Bladder Cancer High-grade Ta T1 Papillary

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-23
Clinical Trial Update: Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin [Phase 2]
Phase 2 clinical trial update for Cretostimogene in non-muscle-invasive bladder cancer unresponsive to BCG, currently recruiting by Lepu Bio…